Second-generation antidepressant

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Second-generation antidepressant
Drug class
Class identifiers
UseDepressive disorders
External links
In Wikidata

The second-generation antidepressants are a class of antidepressants characterized primarily by the era of their introduction, approximately coinciding with the 1970s and 1980s, rather than by their chemical structure or by their pharmacological effect. As a consequence, there is some controversy over which treatments actually belong in this class.

The term "third generation antidepressant" is sometimes used to refer to newer antidepressants,[1] from the 1990s and 2000s, often selective serotonin reuptake inhibitors (SSRIs) such as; fluoxetine (Prozac), paroxetine (Paxil) and sertraline (Zoloft), as well as some non-SSRI antidepressants such as mirtazapine, nefazodone, venlafaxine, duloxetine and reboxetine. However, this usage is not universal.


This list is not exhaustive, and different sources vary upon which items should be considered second-generation.

See also[edit]


  1. ^ Olver JS, Burrows GD, Norman TR (2001). "Third-generation antidepressants: do they offer advantages over the SSRIs?". CNS Drugs. 15 (12): 941–54. doi:10.2165/00023210-200115120-00004. PMID 11735614.

External links[edit]